Show simple item record

dc.contributor.authorBecker, Christian
dc.contributor.authorLienenklaus, Stefan
dc.contributor.authorJablonska, Jadwiga
dc.contributor.authorBauer, Heike
dc.contributor.authorWeiss, Siegfried
dc.date.accessioned2007-07-23T11:38:53Z
dc.date.available2007-07-23T11:38:53Z
dc.date.issued2007-01-01
dc.identifier.citationJ. Mol. Med. 2007, 85(1):63-73en
dc.identifier.issn0946-2716
dc.identifier.pmid17109130
dc.identifier.doi10.1007/s00109-006-0107-8
dc.identifier.urihttp://hdl.handle.net/10033/12858
dc.description.abstractInterferon-gamma (IFN-gamma) is considered a key cytokine involved in the preventive and defensive responses of T cells against infectious pathogens and tumors. Therefore, the transgenic expression of IFN-gamma in specific T cells appears to be an obvious therapeutic possibility. To directly examine whether IFN-gamma production can be increased in T cells, we introduced an IFN-gamma encoding cDNA into IFN-gamma(-/-) and IFN-gamma(+/+) CD8(+) effector populations by retroviral transduction. Here, we show that CD8 T cells can be equipped with IFN-gamma that increases their capacity to secrete the cytokine. Despite constitutive retroviral IFN-gamma mRNA transcription, translation and secretion of IFN-gamma protein was tightly regulated and only observed in activated T cells. Neither proliferation nor cytolytic activity of CTL was affected by IFN-gamma transduction. Importantly, CD8(+) T cells retrovirally transduced with IFN-gamma exhibit augmented tumor suppressive capacity upon adoptive transfer into IFN-gamma(-/-) mice. Thus, T cells can be readily armed with IFN-gamma without risking immunopathology by dysregulated production of this highly potent proinflammatory cytokine.
dc.format.extent-1 bytes
dc.format.extent-1 bytes
dc.format.extent-1 bytes
dc.format.extent150711 bytes
dc.format.extent-1 bytes
dc.format.extent-1 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.titleCD8(+) T cells armed with retrovirally transduced IFN-gamma.en
dc.typeArticleen
dc.format.digYES
refterms.dateFOA2018-06-13T00:06:40Z
html.description.abstractInterferon-gamma (IFN-gamma) is considered a key cytokine involved in the preventive and defensive responses of T cells against infectious pathogens and tumors. Therefore, the transgenic expression of IFN-gamma in specific T cells appears to be an obvious therapeutic possibility. To directly examine whether IFN-gamma production can be increased in T cells, we introduced an IFN-gamma encoding cDNA into IFN-gamma(-/-) and IFN-gamma(+/+) CD8(+) effector populations by retroviral transduction. Here, we show that CD8 T cells can be equipped with IFN-gamma that increases their capacity to secrete the cytokine. Despite constitutive retroviral IFN-gamma mRNA transcription, translation and secretion of IFN-gamma protein was tightly regulated and only observed in activated T cells. Neither proliferation nor cytolytic activity of CTL was affected by IFN-gamma transduction. Importantly, CD8(+) T cells retrovirally transduced with IFN-gamma exhibit augmented tumor suppressive capacity upon adoptive transfer into IFN-gamma(-/-) mice. Thus, T cells can be readily armed with IFN-gamma without risking immunopathology by dysregulated production of this highly potent proinflammatory cytokine.


Files in this item

Thumbnail
Name:
Becker et al.pdf
Size:
-1bytes
Format:
PDF
Description:
riginal document
Thumbnail
Name:
Figures-BeckerMolMed-rev.ppt
Size:
1.374Mb
Format:
Microsoft PowerPoint

This item appears in the following Collection(s)

Show simple item record